Magnolia Medical Technologies is focused on improving the precision of sepsis testing through its innovative Steripath® device, which significantly reduces blood culture contamination. This solution is aimed at healthcare providers, setting a new benchmark for blood culture integrity with extensive clinical validation and an expanding intellectual property portfolio.
